首页 › 基金 › Michelson Medical Research Foundation, Inc. › GXC
Michelson Medical Research Foundation, Inc. 对 GXC 的持仓历史
SPDR INDEX SHS FDS
Michelson Medical Research Foundation, Inc. 在 Q3 2026 的 13F 申报中披露持有 GXC(SPDR INDEX SHS FDS)16,750 股,市值约 US$1.5M,约占其申报组合的 1.29%,在其申报持仓中市值排名第 20 位。 Michelson Medical Research Foundation, Inc. 最近 12 个申报季度中有 12 个季度披露了 GXC 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Michelson Medical Research Foundation, Inc. 对 GXC 的持仓演变
Michelson Medical Research Foundation, Inc. 于 Q4 2023 首次披露 GXC 持仓:16,750 股(约 US$1.1M)。 该持仓在 Q3 2025 达到峰值 16,750 股,市值约 US$1.8M。 在 12 次申报中,Michelson Medical Research Foundation, Inc. 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 16,750 股、市值约 US$1.5M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 16.75K | $1.14M | 新进 |
| Q1 2024 | 16.75K | $1.10M | 持有 |
| Q2 2024 | 16.75K | $1.15M | 持有 |
| Q3 2024 | 16.75K | $1.38M | 持有 |
| Q4 2024 | 16.75K | $1.27M | 持有 |
| Q1 2025 | 16.75K | $1.44M | 持有 |
| Q2 2025 | 16.75K | $1.47M | 持有 |
| Q3 2025 | 16.75K | $1.76M | 持有 |
| Q4 2025 | 16.75K | $1.62M | 持有 |
| Q1 2026 | 16.75K | $1.56M | 持有 |
| Q2 2026 | 16.75K | $1.45M | 持有 |
| Q3 2026 | 16.75K | $1.45M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GXC 与 13F 数据
GXC(SPDR INDEX SHS FDS)的行业分类暂缺。我们追踪的基金中还有 22 只申报持有 GXC,申报仓位最大的包括:OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC (US$17.5M), swisspartners Advisors Ltd (US$12.9M), Prism Advisors, Inc. (US$7.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GXC 的基金
- OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC 201.35K 股 · $17.47M · Q3 2026
- swisspartners Advisors Ltd 149.23K 股 · $12.93M · Q3 2026
- Prism Advisors, Inc. 93.61K 股 · $7.95M · Q3 2026
- Mittelman Wealth Management 27.16K 股 · $2.36M · Q3 2026
更多关于 Michelson Medical Research Foundation, Inc.
常见问题
How long has Michelson Medical Research Foundation, Inc. held GXC?
Michelson Medical Research Foundation, Inc. has disclosed GXC holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Michelson Medical Research Foundation, Inc.'s current position in GXC?
As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 16.75K shares of GXC (SPDR INDEX SHS FDS), valued at $1.45M, representing 1.29% of its reported portfolio and ranking #20.
Has Michelson Medical Research Foundation, Inc. been buying or selling GXC?
In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in GXC. The position peaked in Q3 2025 at 16.75K shares.
Which other funds hold GXC?
Other major institutional holders of GXC include OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC, swisspartners Advisors Ltd, Prism Advisors, Inc., among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.